TOLEROGENIC SYNTHETIC NANOCARRIERS AND THERAPEUTIC MACROMOLECULES FOR REDUCED OR ENHANCED PHARMACODYNAMIC EFFECTS

Title:

TOLEROGENIC SYNTHETIC NANOCARRIERS AND THERAPEUTIC MACROMOLECULES FOR REDUCED OR ENHANCED PHARMACODYNAMIC EFFECTS

Document Type and Number:

Japanese Patent JP2022025069

Kind Code:

A

Abstract:

To provide compositions and methods that provide pharmacodynamic effects specific to therapeutic macromolecules.SOLUTION: The effects may result from reduced doses of therapeutic macromolecules in combination with immunosuppressant doses. The effects may also be enhanced with such compositions.SELECTED DRAWING: None

More Like This:

JP2017522886	Human-derived anti-huntingtin (HTT) antibody and its use
JP6735229	Targeting O-Acetylated GD2 Ganglioside as a New Therapeutic and Diagnostic Strategy for Cancer Stem Cell Cancer
JP2015163606	COMPOSITION FOR ACCELERATING PENETRATION THROUGH SKIN, PREPARATION FOR TRANSDERMAL ADMINISTRATION, AND SKIN PATCH PREPARATION

Inventors:

ROBERTO A MALDONADO
TAKASHI KEI KISHIMOTO

Application Number:

JP2021162235A

Publication Date:

February 09, 2022

Filing Date:

September 30, 2021

Export Citation:

Click for automatic bibliography generation Help

Assignee:

SELECTA BIOSCIENCES INC

International Classes:

A61K45/00; A61K9/127; A61K9/51; A61K31/436; A61K38/19; A61K38/20; A61K38/36; A61K38/37; A61K38/43; A61K38/45; A61K38/51; A61K38/52; A61K38/53; A61K39/395; A61K47/34; A61P37/06; A61P43/00

Foreign References:

WO2012149255A2

2012-11-01

Attorney, Agent or Firm:

Kiyokazu

Previous Patent: JPWO2022025068

Next Patent: Devices, methods, and graphical user interfaces for manipulating the user interface based on unlock ...